Driven by Our Patients
Meet Us at an Event
Prescribing information for HAEGARDA® and Berinert® may vary depending on local approval in each country. Therefore, before prescribing HAEGARDA® or Berinert®, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics (SmPC) in your country.
HAEGARDA® and Berinert® are not available in all countries. Consult the CSL Behring Global Products List to see if HAEGARDA® and Berinert® are available in your country.
- CSL Ltd Annual Report 2022. CSL Ltd. Published 2022. Accessed September 6, 2022. https://investors.csl.com/annualreport/2022/2/